Beauty Health CO 10-Q quarterly reports

SkinHealth Systems Inc. reported a decline in net sales for the second quarter of 2026, alongside increased interest expenses and significant legal matters, though gross margin improved.

SkinHealth Systems reports a net loss of $6.6 million for Q1 2026 as the company navigates macroeconomic headwinds and ongoing legal proceedings.

The Beauty Health Company reported a net loss of $11.0 million in Q3 2025, alongside a significant debt exchange and ongoing legal challenges.

The Beauty Health Company reported a net income of $19.7 million in Q2 2025, driven by a significant debt exchange gain, despite a 13.7% decline in net sales.

The Beauty Health Company reported a 14.5% decrease in first-quarter net sales to $69.6 million year-over-year, primarily due to lower delivery system sales, while consumables revenue grew and gross margin improved as the company restructures its China operations and contends with multiple legal challenges.

The Beauty Health Company's Q3 2024 results show a decrease in revenue, particularly in delivery systems, alongside ongoing legal challenges and inventory adjustments.

The Beauty Health Company experienced a decrease in delivery system sales but saw growth in consumables, alongside a strategic repurchase of convertible notes, impacting their second-quarter financial results.

The Beauty Health Company's Q1 2024 results show a decrease in overall sales, primarily due to lower delivery system sales, partially offset by growth in consumables, and a net loss of $0.7 million.